CANU, LETIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.241
EU - Europa 3.766
AS - Asia 3.261
SA - Sud America 584
AF - Africa 78
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.156
RU - Federazione Russa 1.296
SG - Singapore 895
IT - Italia 890
CN - Cina 780
PL - Polonia 581
HK - Hong Kong 517
BR - Brasile 465
VN - Vietnam 345
KR - Corea 281
IE - Irlanda 243
SE - Svezia 169
FR - Francia 112
FI - Finlandia 106
DE - Germania 100
IN - India 96
BD - Bangladesh 81
GB - Regno Unito 79
ID - Indonesia 59
JO - Giordania 51
JP - Giappone 49
AR - Argentina 48
CA - Canada 47
CH - Svizzera 37
AU - Australia 34
LU - Lussemburgo 33
NL - Olanda 25
EC - Ecuador 24
MX - Messico 24
ES - Italia 23
IQ - Iraq 23
UA - Ucraina 17
ZA - Sudafrica 17
TR - Turchia 16
BE - Belgio 14
MA - Marocco 14
PK - Pakistan 12
PY - Paraguay 11
CI - Costa d'Avorio 10
CO - Colombia 10
LT - Lituania 9
AT - Austria 8
CL - Cile 8
CZ - Repubblica Ceca 7
NP - Nepal 7
PE - Perù 7
BJ - Benin 6
PH - Filippine 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
JM - Giamaica 5
NG - Nigeria 5
TN - Tunisia 5
VE - Venezuela 5
AL - Albania 4
KE - Kenya 4
UZ - Uzbekistan 4
DZ - Algeria 3
KZ - Kazakistan 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
MM - Myanmar 2
RO - Romania 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NA - Namibia 1
OM - Oman 1
PT - Portogallo 1
RE - Reunion 1
RS - Serbia 1
Totale 12.964
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.119
Ashburn 805
Singapore 701
Warsaw 575
Hong Kong 459
Fairfield 377
Seoul 281
San Jose 248
Dublin 243
Hefei 231
Woodbridge 184
Chandler 168
Milan 161
Seattle 150
Beijing 145
Houston 145
Cambridge 139
Ho Chi Minh City 119
Council Bluffs 112
Wilmington 112
Ann Arbor 102
Florence 96
Moscow 95
Los Angeles 81
Altamura 79
Lawrence 78
Hanoi 75
Lauterbourg 68
Buffalo 65
New York 64
Rome 64
The Dalles 64
Princeton 60
Mumbai 51
Boston 48
Helsinki 45
Jakarta 45
Munich 45
São Paulo 39
Kent 38
Paris 37
Bern 32
Dallas 32
Shanghai 32
Melbourne 30
Tokyo 30
Lappeenranta 29
Naples 26
Boardman 21
Dong Ket 20
Haiphong 19
Clifton 18
Luxembourg 18
San Diego 18
Bologna 17
Turku 17
Orem 16
Rio de Janeiro 16
Toronto 16
West Jordan 16
Dudelange 15
Scuola 15
Brussels 14
Genoa 14
Medford 14
Redondo Beach 14
Turin 14
Chicago 13
Falls Church 13
Bengaluru 12
Frankfurt am Main 12
Montreal 12
Brooklyn 11
Da Nang 11
Guangzhou 11
Abidjan 10
Barcelona 10
Guayaquil 10
London 10
Palermo 10
Baghdad 9
Belo Horizonte 9
Chennai 9
Gumyojicho 9
Johannesburg 9
Mexico City 9
Poplar 9
Prato 9
Redmond 9
Atlanta 8
Bremen 8
Brescia 8
Cagliari 8
Curitiba 8
Jacksonville 8
Norwalk 8
Yubileyny 8
Biên Hòa 7
Brasília 7
Casablanca 7
Totale 8.647
Salva come PNG Salva come JPEG
Nome #
2D-DIGE proteomic analysis identifies new potential therapeutic targets for adrenocortical carcinoma 358
Metformin as a new anti-cancer drug in adrenocortical carcinoma 313
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 304
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 296
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 231
S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study 229
DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ADRENOCORTICAL CARCINOMA: A MONOCENTRIC PRELIMINARY STUDY. 221
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 217
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 212
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 206
The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide 203
Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. 199
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 194
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 192
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 185
Morphofunctional effects of mitotane on mitochondria in human adrenocortical cancer cells. 185
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 182
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE). 181
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 181
[68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation 180
Novel Somatic Mutations in the Catalytic Subunit of the Protein Kinase A as a Cause of Adrenal Cushing's Syndrome: A European Multicentric Study. 180
Caratterizzazione genomica del carcinoma surrenalico 179
Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors 178
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 178
Case Report: Adrenocortical Oncocytoma in a Patient with a Previous Contralateral Adrenalectomy for a Cortisol-Secreting Adenoma 177
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 172
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 170
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma 170
The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids 169
Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function 168
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 167
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 166
New Findings on Presentation and Outcome of Patients With Adrenocortical Cancer: Results From a National Cohort Study 165
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 165
The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland 165
Ipertensione ed esercizio fisico 162
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 161
Intratumour microbiota modulates adrenocortical cancer responsiveness to mitotane 160
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/ mTOR axis in metastatic pheochromocytoma/ paraganglioma 160
Tumour microenvironment in pheochromocytoma and paraganglioma 158
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. 157
Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study 157
Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer 155
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 155
Adrenocortical carcinoma: Current treatment options 153
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 151
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 151
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 151
Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-PronO study): A European network for the study of adrenal tumors retrospective study 149
Analysis of telomere maintenance related genes reveals NOP10 as a new metastatic-risk marker in pheochromocytoma/paraganglioma 149
Feocromocitoma/Paraganglioma: aspetti radiologici ed associazione con seconde neoplasie. 146
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question 146
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 145
Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma 145
Cancer-testis Antigen FATE1 Expression in Adrenocortical Tumors Is Associated with A Pervasive Autoimmune Response and Is A Marker of Malignancy in Adult, but Not Children, ACC 145
[Arterial hypertension and RU-486: a complex case of secondary hypertension] 144
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: A multicenter interobserver variation analysis using virtual microscopy: A Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) 143
Urine steroid metabolomics as a novel tool for detection of recurrent adrenocortical carcinoma 141
Metodiche di dosaggio di metanefrine e catecolamine: rischi e variabili interpretative per i dosaggi effettuati in centri non specializzati 140
Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview 133
ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma 132
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 131
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study 129
Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) 129
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 127
Pitfalls in Genetic Analysis of Pheochromocytomas/Paragangliomas-Case Report. 125
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 125
Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction 123
Mass spectrometry imaging identifies metabolic patterns associated with malignant potential in pheochromocytoma and paraganglioma 123
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma 118
Malignant Pheochromocytoma 115
Pheochromocytomas and paragangliomas as causes of endocrine hypertension 110
Pros and cons of surgical versus conservative management for head and neck paraganglioma: a real-world data analysis 102
Use and utility of endocrine multidisciplinary tumour board: an appraisal from a tertiary centre 100
The penetrance of MEN2 pheochromocytoma is not only determined byRETmutations 96
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas 88
High Filamin a Expression in Adrenocortical Carcinomas Is Associated with a Favourable Tumour Behaviour: A European Multicentric Study 86
Volumetric evaluation of CT images of adrenal glands in primary aldosteronism 83
Hypertension and Cushing’s syndrome: hunt for the red flag 77
An innovative nuclear antigen-based approach for single-cell isolation of circulating tumor cells in adrenal cortical carcinoma 45
Presurgical Succinate MetAstatic Risk Tool (P-SMART) in Paragangliomas 41
In-depth Genetic and Molecular Characterization of Unilateral Coexisting Adrenal Cortical Adenoma and Carcinoma in the Context of MEN1 Syndrome 34
Clinical Predictors of Outcome in Advanced Adrenocortical Carcinoma: a multicentre international ENSAT study 26
Systematic review of multimodal management strategies for Insulinoma-Induced hypoglycaemia: current evidence and future directions. 19
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy. 19
Multicentric Retrospective Analysis of Oncocytic Adrenocortical Carcinoma: Insights into Clinical and Management Strategies 19
Mechanical Circulatory Support in Paraganglioma Induced Cardiogenic Shock and Intestinal Ischemia: Lessons from a Complex Case and Narrative Review 17
Totale 13.134
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.648
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022396 10 28 26 34 21 24 10 59 17 24 32 111
2022/20231.000 95 238 41 59 48 149 148 39 106 18 22 37
2023/2024619 11 47 87 29 49 99 19 109 33 66 52 18
2024/20253.792 116 384 226 634 920 476 103 336 104 119 178 196
2025/20265.186 510 726 499 540 506 184 532 231 302 391 203 562
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 13.134